Results 121 to 130 of about 278,920 (305)

The role of medication regimen complexity in diabetes management: a rapid review

open access: yesTherapeutic Advances in Endocrinology and Metabolism
Combination therapy is commonly used to achieve better glycemic control, but Medication Regimen Complexity (MRC) can pose challenges for treatment adherence and outcomes.
Sarah M. Khayyat, Ruba S. Azfr Ali
doaj   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia   +16 more
wiley   +1 more source

Performance Analysis of DE-QPSK with Joint Transmit and Receive Diversity in Nakagami Fading

open access: yesDianxin kexue, 2015
By using the statistical average results of higher-order powers of Gaussian Q-function in multi-branch diversity reception with maximum ratio combining(MRC)in Rayleigh fading channel,exact closed-form for the average symbol error rate(ASER)of ...
Guangqiu Li, Jiayun Dong
doaj   +2 more sources

Population pharmacokinetics of levofloxacin in breastmilk in patients with rifampicin‐resistant tuberculosis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Levofloxacin is a widely used antibiotic included in rifampicin‐resistant tuberculosis (RR‐TB) treatment. Data describing levofloxacin concentrations in breastmilk and infant exposure are limited. We analysed data from two South African studies of breastfeeding women receiving levofloxacin (750–1000 mg daily) for RR‐TB.
Sharon Sawe   +9 more
wiley   +1 more source

Neurofilament light chain as in vitro and clinical biomarker of vincristine‐induced peripheral neuropathy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Vincristine‐induced peripheral neuropathy (VIPN) is a common side effect in children and adolescents treated with vincristine. Assessing VIPN, especially in young children, is challenging due to a lack of sensitive tools. This limits our understanding of the nature and risk factors of VIPN. This study aimed to investigate neurofilament light chain
Peter Erik Lotko Pontoppidan   +8 more
wiley   +1 more source

Optimizing the Master Recession Curve for Watershed Characterization and Drought Preparedness in Eastern Cape, South Africa

open access: yesHydrology
Regions grappling with water scarcity are compelled to fortify their hydrological analytical protocols for efficacious drought disaster preparedness, considering the escalating influence of climate change on river periodicity and the sustainable ...
Solomon Temidayo Owolabi   +1 more
doaj   +1 more source

Case‐malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Many women take medications during pregnancy. However, the risk to the fetus from most medications is uncertain. Congenital anomalies are one of the leading causes of infant death and contribute to long‐term disability. Signal detection methods can be used to systematically identify possible medication–anomaly associations that require further ...
Hannah Johnson   +22 more
wiley   +1 more source

MRC annual reports FY2015 & FY2016

open access: yes, 2016
The Media Resources Center (MRC) provides an array of media technology services for the university and community. For more information, visit the MRC website: http://www.wichita.edu/thisis/home/?u=mrcweb2 (accessed August 18, 2015.
Media Resources Center, Academic Affairs
core  

UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Irinotecan, a topoisomerase I inhibitor, is available as both non‐pegylated and pegylated formulations. The non‐pegylated formulation is licensed for use in advanced colorectal cancer either in combination with other agents or as monotherapy.
Dharmisha Chauhan   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy